Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 41, 2019 - Issue 3
Submit an article Journal homepage
281
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response

Jaewoong JangDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; View further author information
,
Yoonju JungDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; View further author information
,
Seyeon ChaeDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; View further author information
,
Taehyun BaeDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; View further author information
,
Seok-Min KimSchool of Mechanical Engineering, Chung-Ang University, Seoul, Republic of Korea; View further author information
,
Yae Jie ShimCollege of General Studies, Sangmyung University, Seoul, Republic of KoreaCorrespondence[email protected] [email protected]
View further author information
,
Sang-In ChungDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; Correspondence[email protected] [email protected]
View further author information
&
Yoosik YoonDepartment of Microbiology, Chung-Ang University College of Medicine, Seoul, Republic of Korea; Correspondence[email protected] [email protected]
View further author information
 show all
Pages 394-402 | Received 21 Apr 2018, Accepted 05 Oct 2018, Published online: 22 Nov 2018

References

  • Zimmerman ZF, Moon RT, Chien AJ. Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol. 2012;4:a008086.
  • Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60.
  • Luu HH, Zhang R, Haydon RC, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004;4:653–671.
  • Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci. 2006;119:395–402.
  • Huang SM, Mishina YM, Liu S, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009;461:614–620.
  • Kirby CA, Cheung A, Fazal A, et al. Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012;68:115–118.
  • Tian XH, Hou WJ, Fang Y, et al. XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 2013;32:100.
  • Tian X, Hou W, Bai S, et al. XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1. Int J Oncol. 2014;45:121–128.
  • Jang J, Ha JH, Chung SI, et al. Beta-catenin regulates NF-kappaB activity and inflammatory cytokine expression in bronchial epithelial cells treated with lipopolysaccharide. Int J Mol Med. 2014;34:632–638.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
  • Seo E, Jho EH. Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin. Biochem Biophys Res Commun. 2007;357:81–86.
  • Li J, Zhang D, Ward KM, et al. Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro. Toxicol in Vitro. 2012;26:603–612.
  • Ivanenkov YA, Balakin KV, Lavrovsky Y. Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics. Mini Rev Med Chem. 2011;11:55–78.
  • Guo W, Shen F, Xiao W, et al. Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis. Oncol Lett. 2017;14:6585–6591.
  • Wu X, Luo F, Li J, et al. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Int J Oncol. 2016;48:1333–1340.
  • Chen J, Li J, Miao Z, et al. XAV939, a small molecular inhibitor, provides neuroprotective effects on oligodentrocytes. J Neurosci Res. 2014;92:1252–1258.
  • Chen L, Zhuang J, Singh S, et al. XAV939 inhibits intima formation by decreasing vascular smooth muscle cell proliferation and migration through blocking Wnt signaling. J Cardiovasc Pharmacol. 2016;68:414–424.
  • Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993;90:10193–10197.
  • Koopmans T, Eilers R, Menzen M, et al. Beta-catenin directs nuclear factor-kappaB p65 output via CREB-binding protein/p300 in human airway smooth muscle. Front Immunol. 2017;8:1086.
  • Bandino A, Compagnone A, Bravoco V, et al. Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase. Int J Biochem Cell Biol. 2008;40:1861–1871.
  • Lin JC, Chang RL, Chen YF, et al. β-Catenin overexpression causes an increase in inflammatory cytokines and NF-κB activation in cardiomyocytes. Cell Mol Biol. 2016;63:17–22.
  • Montefort S, Herbert CA, Robinson C, et al. The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy. 1992;22:511–520.
  • Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217–225.
  • Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res. 2003;9:293–300.
  • Striz I, Mio T, Adachi Y, et al. The CD14 molecule participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells. Immunol Lett. 1998;62:177–181.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.